Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |